Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q4 2021 Results - Earnings Call Transcript

SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q4 2021 Results - Earnings Call Transcript

Syros Pharmaceuticals Inc.
Syros Pharmaceuticals, Inc. (SYRS) Q4 2021 Financial Results Conference Call March 15, 2022, 08:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications and Investor Relations Nancy Simonian - Chief Executive Officer Jason Haas - Chief Financial Officer David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conley Chee - Chief Commercial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Phil Nadeau - Cowen & Company Zegbeh Jallah - Roth International Matthew Cross - Alliance Global Partners Presentation Operator Good morning and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of Syros’ website at www.syros.com. Please be advised that today's conference is being recorded. At this time I would like to turn

For further details see:

Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Syros Pharmaceuticals Inc.
Stock Symbol: SYRS
Market: NASDAQ
Website: syros.com
Menu
SYRS SYRS Quote SYRS Short SYRS News SYRS Articles SYRS Message Board
Get SYRS Alerts

News, Short Squeeze, Breakout and More Instantly...